These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 39315196)

  • 21. The gut microbiota: A new target in the management of alcohol dependence?
    Leclercq S; Stärkel P; Delzenne NM; de Timary P
    Alcohol; 2019 Feb; 74():105-111. PubMed ID: 30031625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unlocking the gut-heart axis: exploring the role of gut microbiota in cardiovascular health and disease.
    Shariff S; Kwan Su Huey A; Parag Soni N; Yahia A; Hammoud D; Nazir A; Uwishema O; Wojtara M
    Ann Med Surg (Lond); 2024 May; 86(5):2752-2758. PubMed ID: 38694298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia.
    Jia X; Xu W; Zhang L; Li X; Wang R; Wu S
    Front Cell Infect Microbiol; 2021; 11():634780. PubMed ID: 34490132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-Housing and Fecal Microbiota Transplantation: Technical Support for TCM Herbal Treatment of Extra-Intestinal Diseases Based on Gut Microbial Ecosystem Remodeling.
    Sun X; Zhou X; He W; Sun W; Xu Z
    Drug Des Devel Ther; 2023; 17():3803-3831. PubMed ID: 38155743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression.
    Li B; Xu M; Wang Y; Feng L; Xing H; Zhang K
    J Ethnopharmacol; 2023 Mar; 303():116038. PubMed ID: 36529248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota and integrative traditional Chinese and western medicine in prevention and treatment of heart failure.
    Cui H; Han S; Dai Y; Xie W; Zheng R; Sun Y; Xia X; Deng X; Cao Y; Zhang M; Shang H
    Phytomedicine; 2023 Aug; 117():154885. PubMed ID: 37302262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological mechanisms of Ma Xing Shi Gan Decoction in treating influenza virus-induced pneumonia: intestinal microbiota and pulmonary glycolysis.
    Jiang L; Bai C; Zhu J; Su C; Wang Y; Liu H; Li Q; Qin X; Gu X; Liu T
    Front Pharmacol; 2024; 15():1404021. PubMed ID: 39161892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota in COVID-19: new insights from inside.
    Zhou B; Pang X; Wu J; Liu T; Wang B; Cao H
    Gut Microbes; 2023; 15(1):2201157. PubMed ID: 37078497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
    Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
    Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the gut microbiota and sarcopenia: a systematic review.
    Liu C; Cheung WH; Li J; Chow SK; Yu J; Wong SH; Ip M; Sung JJY; Wong RMY
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1393-1407. PubMed ID: 34523250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding how pre- and probiotics affect the gut microbiome and metabolic health.
    Bock PM; Martins AF; Schaan BD
    Am J Physiol Endocrinol Metab; 2024 Jul; 327(1):E89-E102. PubMed ID: 38809510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiome-Metabolomics Analysis of the Impacts of
    Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
    Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
    Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota: A new target for T2DM prevention and treatment.
    Liu L; Zhang J; Cheng Y; Zhu M; Xiao Z; Ruan G; Wei Y
    Front Endocrinol (Lausanne); 2022; 13():958218. PubMed ID: 36034447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbial Metabolites: Critical Regulators in NAFLD.
    Dai X; Hou H; Zhang W; Liu T; Li Y; Wang S; Wang B; Cao H
    Front Microbiol; 2020; 11():567654. PubMed ID: 33117316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective.
    Lin X; Han H; Wang N; Wang C; Qi M; Wang J; Liu G
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Microbiota-Gut Metabolites and
    Gurung B; Stricklin M; Wang S
    Metabolites; 2024 Jan; 14(1):. PubMed ID: 38276309
    [No Abstract]   [Full Text] [Related]  

  • 40. Bile acids metabolism involved in the beneficial effects of Danggui Shaoyao San via gut microbiota in the treatment of CCl
    Zhao Y; Zhao M; Zhang Y; Fu Z; Jin T; Song J; Huang Y; Zhao C; Wang M
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117383. PubMed ID: 37925004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.